Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors

Proteomics

Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors

Featured Speaker: Caroline Le Poole, PhD, Professor of Dermatology and Microbiology-Immunology at Northwestern University Feinberg School of Medicine

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Review published data showing how polyfunctional GD3 CAR T cells created to target the TSC tumor immunogens can substantially reduce tumor burden in a mouse model.

Learn how IsoPlexis' single-cell multiplex cytokine profiling uncovered rare polyfunctional CAR T cell subsets indicating the functional capacity for improved anti-tumor response.

Watch the Q&A session with our expert panelist.

Explore Related Resources

Access related webinars, eBooks, app notes & case studies.

Webinar

The Many Facets of T Cell Exhaustion

Blog

Single-Cell Functional Proteomics Reveals TSC Tumor Response to CAR T Cell Treatment

Application Note

IsoPlexis Proteomic Product Suite for CAR-T Therapy

Watch the Webinar

Back to the Top